<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">09-PONE-RA-09238R1</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0006634</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Biochemistry/Drug Discovery</subject><subject>Cell Biology/Cellular Death and Stress Responses</subject><subject>Nephrology/Dialysis and Renal Transplantation</subject></subj-group></article-categories><title-group><article-title>A Nanoconjugate Apaf-1 Inhibitor Protects Mesothelial Cells from Cytokine-Induced Injury</article-title><alt-title alt-title-type="running-head">Apaf-1 Targeting and Cytokines</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Santamar&#x000ed;a</surname><given-names>Beatriz</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Benito-Martin</surname><given-names>Alberto</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ucero</surname><given-names>Alvaro Conrado</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Aroeira</surname><given-names>Luiz Stark</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Reyero</surname><given-names>Ana</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Vicent</surname><given-names>Mar&#x000ed;a Jes&#x000fa;s</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Orz&#x000e1;ez</surname><given-names>Mar</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Celdr&#x000e1;n</surname><given-names>Angel</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Esteban</surname><given-names>Jaime</given-names></name><xref ref-type="aff" rid="aff8"><sup>8</sup></xref></contrib><contrib contrib-type="author"><name><surname>Selgas</surname><given-names>Rafael</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ru&#x000ed;z-Ortega</surname><given-names>Marta</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cabrera</surname><given-names>Manuel L&#x000f3;pez</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Egido</surname><given-names>Jes&#x000fa;s</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>P&#x000e9;rez-Pay&#x000e1;</surname><given-names>Enrique</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ortiz</surname><given-names>Alberto</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Dialysis Unit, Fundaci&#x000f3;n Jim&#x000e9;nez D&#x000ed;az, Universidad Aut&#x000f3;noma de Madrid, Instituto Reina Sof&#x000ed;a de Investigaci&#x000f3;n Nefrol&#x000f3;gica, Madrid, Spain</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Servicio de Nefrolog&#x000ed;a, Hospital Universitario La Paz, Madrid, Spain</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Polymer Therapeutics Laboratory, Department of Medicinal Chemistry, Centro de Investigaci&#x000f3;n Pr&#x000ed;ncipe Felipe, Valencia, Spain</addr-line></aff><aff id="aff4"><label>4</label><addr-line>Laboratory of Renal and Vascular Research, Universidad Aut&#x000f3;noma de Madrid, Madrid, Spain</addr-line></aff><aff id="aff5"><label>5</label><addr-line>Molecular Biology Department, Hospital Universitario de la Princesa, Madrid, Spain</addr-line></aff><aff id="aff6"><label>6</label><addr-line>Peptide and Protein Laboratory, Department of Medicinal Chemistry, Centro de Investigaci&#x000f3;n Pr&#x000ed;ncipe Felipe, Valencia, Spain</addr-line></aff><aff id="aff7"><label>7</label><addr-line>Instituto de Biomedicina de Valencia CSIC, Valencia, Spain</addr-line></aff><aff id="aff8"><label>8</label><addr-line>Servicio de Microbiolog&#x000ed;a, Fundaci&#x000f3;n Jimenez D&#x000ed;az, Madrid, Spain</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Bonini</surname><given-names>Marcelo</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">National Institutes of Health (NIH)/National Institute of Environmental Health Sciences (NIEHS), United States of America</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>aortiz@fjd.es</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: BS ABM ACU LSA AO. Performed the experiments: BS ABM ACU LSA. Analyzed the data: BS ABM ACU AO. Contributed reagents/materials/analysis tools: BS LSA AmR MJV MO AC JE RS MRO MLC JE EPP AO. Wrote the paper: BS ABM ACU MJV MRO EPP AO.</p></fn></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>13</day><month>8</month><year>2009</year></pub-date><volume>4</volume><issue>8</issue><elocation-id>e6634</elocation-id><history><date date-type="received"><day>16</day><month>3</month><year>2009</year></date><date date-type="accepted"><day>23</day><month>6</month><year>2009</year></date></history><permissions><copyright-statement>Santamar&#x000ed;a et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement></permissions><abstract><sec><title>Background</title><p>Inflammation may lead to tissue injury. We have studied the modulation of inflammatory milieu-induced tissue injury, as exemplified by the mesothelium. Peritoneal dialysis is complicated by peritonitis episodes that cause loss of mesothelium. Proinflammatory cytokines are increased in the peritoneal cavity during peritonitis episodes. However there is scarce information on the modulation of cell death by combinations of cytokines and on the therapeutic targets to prevent desmesothelization.</p></sec><sec><title>Methodology</title><p>Human mesothelial cells were cultured from effluents of stable peritoneal dialysis patients and from omentum of non-dialysis patients. Mesothelial cell death was studied in mice with <italic>S. aureus</italic> peritonitis and in mice injected with tumor necrosis factor alpha and interferon gamma.</p><p>Tumor necrosis factor alpha and interferon gamma alone do not induce apoptosis in cultured mesothelial cells. By contrast, the cytokine combination increased the rate of apoptosis 2 to 3-fold over control. Cell death was associated with the activation of caspases and a pancaspase inhibitor prevented apoptosis. Specific caspase-8 and caspase-3 inhibitors were similarly effective. Co-incubation with both cytokines also impaired mesothelial wound healing in an in vitro model. However, inhibition of caspases did not improve wound healing and even impaired the long-term recovery from injury. By contrast, a polymeric nanoconjugate Apaf-1 inhibitor protected from apoptosis and allowed wound healing and long-term recovery. The Apaf-1 inhibitor also protected mesothelial cells from inflammation-induced injury in vivo in mice.</p></sec><sec><title>Conclusion</title><p>Cooperation between tumor necrosis factor alpha and interferon gamma contributes to mesothelial injury and impairs the regenerative capacity of the monolayer. Caspase inhibition attenuates mesothelial cell apoptosis but does not facilitate regeneration. A drug targeting Apaf-1 allows protection from apoptosis as well as regeneration in the course of inflammation-induced tissue injury.</p></sec></abstract><counts><page-count count="14"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Tissue injury is an unwanted adverse effect of inflammation. Peritoneal dialysis (PD) is a renal replacement therapy modality that is marred by episodes of bacterial infection, leading to localized inflammation evidenced as peritonitis <xref ref-type="bibr" rid="pone.0006634-Heimburger1">&#x0005b;1&#x0005d;</xref>. PD represents an interesting model of inflammation since the technique consists of and allows repeated non-invasive access to the peritoneal cavity, allowing both monitoring of the inflammatory process as well as therapy by local delivery of drugs. Currently the therapy of peritonitis consists of local intraperitoneal delivery of antibiotics and heparin <xref ref-type="bibr" rid="pone.0006634-Piraino1">&#x0005b;2&#x0005d;</xref>. One of the main peritoneal manifestations of inflammatory tissue injury is loss of mesothelial cells, which occurs both during chronic PD and in acute inflammatory episodes <xref ref-type="bibr" rid="pone.0006634-Di1">&#x0005b;3&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Verger1">&#x0005b;4&#x0005d;</xref>. Apoptotic mesothelial cells are lost in the peritoneal effluent of stable PD patients and the number of peritoneal effluent apoptotic mesothelial cells increases 80-fold during peritonitis <xref ref-type="bibr" rid="pone.0006634-Chen1">&#x0005b;5&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0006634-Santamaria1">&#x0005b;7&#x0005d;</xref>. Counting effluent apoptotic cells will underestimate apoptosis, since the apoptotic features have a half-life of 1&#x02013;2 hours and most apoptotic cells are engulfed by phagocytes <xref ref-type="bibr" rid="pone.0006634-Baker1">&#x0005b;8&#x0005d;</xref>. Lethal cytokines are among the endogenous mediators that cause mesothelial cell death <xref ref-type="bibr" rid="pone.0006634-Chen1">&#x0005b;5&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Catalan1">&#x0005b;6&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Ortiz1">&#x0005b;9&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0006634-Heath1">&#x0005b;11&#x0005d;</xref>. FasL directly promotes mesothelial cell apoptosis <xref ref-type="bibr" rid="pone.0006634-Catalan1">&#x0005b;6&#x0005d;</xref>. By contrast, neither TNF nor TRAIL alone modulate mesothelial cell survival <xref ref-type="bibr" rid="pone.0006634-Catalan1">&#x0005b;6&#x0005d;</xref>. However, most extracellular inputs are not processed in isolation, rather, multiple inputs are perceived and integrated by cells in a proinflammatory milieu <xref ref-type="bibr" rid="pone.0006634-Janes1">&#x0005b;12&#x0005d;</xref>. In this regard, mesothelial cells are immersed in a complex microenvironment and inflammatory cytokines may cooperate to influence on mesothelial cell fate. Other inflammatory mediators, bacterial infection, tumor cells, PD solutions and asbestos also promote mesothelial cell apoptosis <xref ref-type="bibr" rid="pone.0006634-Santamaria1">&#x0005b;7&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Heath1">&#x0005b;11&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Broaddus1">&#x0005b;13&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0006634-HaslingerLoffler1">&#x0005b;18&#x0005d;</xref>.</p><p>Apoptosis is an active model of cell death that regulates cell number <xref ref-type="bibr" rid="pone.0006634-Ortiz1">&#x0005b;9&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Ortiz2">&#x0005b;19&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Sanz1">&#x0005b;20&#x0005d;</xref>. Understanding the regulation of apoptosis has possible therapeutic relevance, since it is regulated by the activation of intracellular lethal molecules in response to the cell microenvironment <xref ref-type="bibr" rid="pone.0006634-Ortiz1">&#x0005b;9&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Ortiz2">&#x0005b;19&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0006634-Strasser1">&#x0005b;21&#x0005d;</xref>. Among them, caspases are a family of intracellular cysteine proteases that behave as activators and effectors of apoptosis, and play a central role in the process <xref ref-type="bibr" rid="pone.0006634-Sanz1">&#x0005b;20&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Ortiz3">&#x0005b;22&#x0005d;</xref>. Caspase-8 is the canonical initiator caspase engaged by lethal cytokines that activate cell death receptors. In turn, caspase-8 recruits the mitochondrial pathway for apoptosis and activates executioner caspases, such as caspase-3, that are responsible for cell death. Activation of the mitochondrial pathway, leads to the release of proapoptotic molecules such as cytochrome c into the cytoplasm, which, in the presence of dATP, induce the formation of the Apaf-1 (apoptotic protease activating factor 1)-containing macromolecular complex called the apoptosome. This complex, in turn, binds to and activates caspase-9. Mature caspase-9 activates effector caspases <xref ref-type="bibr" rid="pone.0006634-Li1">&#x0005b;23&#x0005d;</xref>. Caspase inhibitors prevent leukocyte apoptosis induced by conventional, glucose-containing PD solutions <xref ref-type="bibr" rid="pone.0006634-Catalan1">&#x0005b;6&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Catalan2">&#x0005b;24&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Catalan3">&#x0005b;25&#x0005d;</xref>. However, recent reports have emphasized non-apoptotic functions of caspases including promotion of cell proliferation that contributes to tissue regeneration <xref ref-type="bibr" rid="pone.0006634-Ben1">&#x0005b;26&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0006634-Li2">&#x0005b;28&#x0005d;</xref>. In addition, in certain epithelial cell types, caspase inhibition may transform a mild proapoptotic response into an intense necrotic response to lethal cytokines <xref ref-type="bibr" rid="pone.0006634-Justo1">&#x0005b;29&#x0005d;</xref>. We now explore the cooperation between inflammatory cytokines in modulating human mesothelial cell fate and possible therapeutic interventions to prevent mesothelial cell death during inflammation. In particular we have analyzed its modulation by classical caspase inhibitors as well as by targeting the activity of the apoptosome. Recent reports have proposed the apoptosome as an interesting target for the development of apoptosis inhibitors <xref ref-type="bibr" rid="pone.0006634-Malet1">&#x0005b;30&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0006634-Lee2">&#x0005b;32&#x0005d;</xref>. Indeed, our results showed that chemical inhibition of apoptosome activity with a nanoconjugate Apaf-1 inhibitor is effective in protecting mesothelial cells from cytokine-induced apoptosis and, in contrast to caspase inhibition, it allows wound healing and long-term recovery.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>Regulation of mesothelial cell apoptosis by cooperation of inflammatory cytokines</title><p>Acute demesothelization occurs during experimental and human peritonitis, and is associated with an increased rate of mesothelial cell apoptosis <xref ref-type="bibr" rid="pone.0006634-Di1">&#x0005b;3&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0006634-Catalan1">&#x0005b;6&#x0005d;</xref>. During peritoneal inflammation numerous cytokines are released locally. Among them we find IFN&#x003b3; and TNF&#x003b1; <xref ref-type="bibr" rid="pone.0006634-Dasgupta1">&#x0005b;33&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Brauner1">&#x0005b;34&#x0005d;</xref>. Although TNF&#x003b1; is, by itself, a potentially lethal cytokine <xref ref-type="bibr" rid="pone.0006634-Ortiz2">&#x0005b;19&#x0005d;</xref>, we did not observe a lethal effect of TNF&#x003b1; in human peritoneal mesothelial cells (HPMC) cultured from the effluent of stable PD patients (<xref ref-type="fig" rid="pone-0006634-g001"><bold>Fig. 1. A, B</bold></xref>). IFN&#x003b3; increased TNF&#x003b1; lethality (<xref ref-type="fig" rid="pone-0006634-g001"><bold>Fig. 1.A, B</bold></xref>) <xref ref-type="bibr" rid="pone.0006634-Catalan1">&#x0005b;6&#x0005d;</xref>. The combination of cytokines induced HPMC apoptosis in a time- and dose-dependent manner (<xref ref-type="fig" rid="pone-0006634-g001"><bold>Fig. 1.B, C</bold></xref>). By contrast, cytokines had no effect on the percentage of cells on the S or M phase of the cell cycle, as assessed by flow cytometry of DNA content (range 9 to 10&#x00025; for the different conditions). The combination of IFN&#x003b3; and TNF&#x003b1; also induced apoptosis in human omental mesothelial cells (HOMC) cultured from the omentum of non-uremic patients (<xref ref-type="fig" rid="pone-0006634-g001"><bold>Fig. 1.D</bold></xref>).</p><fig id="pone-0006634-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0006634.g001</object-id><label>Figure 1</label><caption><title>Cooperation of cytokines induces apoptosis in mesothelial cells.</title><p>A) Representative flow cytometry of DNA content diagrams. Note the increase in the hypodiploid, apoptotic population in HPMC cultured for 48 h in presence of TNF&#x003b1;/IFN&#x003b3;. B) Quantification of apoptosis in HPMC by flow cytometry. The combination of TNF&#x003b1;/IFN&#x003b3; induces apoptosis. When not specified, 300 U/mL IFN&#x003b3; and 250 ng/mL TNF&#x003b1; were used, &#x0002a; p&#x0003c;0.04 vs each individual cytokine at 24 h. &#x0002a;&#x0002a; p&#x0003c;0.001 vs each individual cytokine at 48 h. &#x00026; p&#x0003c;0.001 vs control. Mean&#x000b1;SEM of 6 different experiments. C) Dose-response in HPMC. Mean&#x000b1;SEM of 4 different experiments &#x0002a; p&#x0003c;0.05 vs control. D) Quantification of apoptosis in HOMC by flow cytometry. The combination TNF&#x003b1;/IFN&#x003b3; for 48 h induces apoptosis. &#x0002a;p&#x0003c;0.005 vs. control. Mean&#x000b1;SEM of 4 different experiments.</p></caption><graphic xlink:href="pone.0006634.g001"/></fig></sec><sec id="s2b"><title>Caspases mediate mesothelial cell apoptosis induced by cytokine cooperation</title><p>HPMC apoptosis induced by TNF&#x003b1; and IFN&#x003b3; was characterized by the appearance of caspase-generated fragments of cytokeratin 8/18 in the cytoplasm and typical morphological features of nuclear apoptosis, such as shrunk, bright and fragmented nuclei (<xref ref-type="fig" rid="pone-0006634-g002"><bold>Fig. 2.A</bold></xref>). Flow cytometry confirmed that TNF&#x003b1; and IFN&#x003b3; increased the number of cells containing caspase-generated fragments of cytokeratin 8/18 (<xref ref-type="fig" rid="pone-0006634-g002"><bold>Fig. 2.B</bold></xref>) and caspase-3 activity was increased by 1.7&#x000b1;0.4 fold over control at 24 h in a colorimetric assay (p&#x0003c;0.02, not shown). Taken together, these data provide evidence for the involvement of caspases in the process. In order to confirm the requirement for caspases and to explore possible therapeutic strategies, cells were treated with caspase inhibitors. The pan-caspase inhibitor, zVAD, or specific caspase-3 (DEVD) or caspase-8 (IETD) inhibitors prevented morphological features of apoptosis induced by cytokines (<xref ref-type="fig" rid="pone-0006634-g002"><bold>Fig. 2.A</bold></xref>) and the activation of executioner caspases (<xref ref-type="fig" rid="pone-0006634-g002"><bold>Fig. 2.A&#x02013;C</bold></xref>), and decreased apoptosis as assessed by the presence of hypodiploid cells (<xref ref-type="fig" rid="pone-0006634-g002"><bold>Fig. 2.D, E</bold></xref>). Similar results were obtained in HOMC (not shown). The most effective caspase inhibitor in decreasing the rate of apoptosis, zVAD, was studied in further detail. In mesothelial cells exposed to TNF&#x003b1; and IFN&#x003b3;, zVAD was unable to prevent eventual cell death (data not shown) despite not increasing the non-apoptotic cytotoxicity of cytokines, as it is the case with other cell types <xref ref-type="bibr" rid="pone.0006634-Justo1">&#x0005b;29&#x0005d;</xref>. Caspase inhibition was not <italic>per se</italic> toxic in cells not exposed to cytokine combinations and did not increase the number of dead cells staining with trypan blue (data not shown).</p><fig id="pone-0006634-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0006634.g002</object-id><label>Figure 2</label><caption><title>Apoptosis induced by cooperation of cytokines is caspase-dependent.</title><p>A) Caspase activation in HPMC exposed to TNF&#x003b1;/IFN&#x003b3; for 24 h. Apoptosis was decreased by zVAD (pan-caspase inhibitor), DEVD (caspase-3 inhibitor) and IETD (caspase-8 inhibitor). Note cytokeratin (CK) 8/18 cleavage by caspases as well as the nuclear apoptotic morphology in cells exposed to TNF&#x003b1;/IFN&#x003b3; (arrowheads). Green: FITC-M30 cytodeath antibody, red: propidium iodide in permeabilized cells. Original magnification &#x000d7;100. B) Representative diagram of detection of caspase-cleaved CK 8/18 by flow cytometry in HPMC. C) Quantification of caspase-cleaved CK 8/18 by flow cytometry in HPMC treated with TNF&#x003b1; and IFN&#x003b3; for 24 h. &#x0002a; p&#x0003c;0.005 vs control and # p&#x0003c;0.05 vs TNF&#x003b1;/IFN&#x003b3;. Mean&#x000b1;SEM of 4 different experiments. D) Flow cytometry diagrams of permeabilized, propidium iodide-stained cells. Note the decrement of hypodiploid cells (arrowhead) in the presence of caspase inhibitors in HPMC. E) Quantification of apoptosis by flow cytometry of DNA content in HPMC exposed to TNF&#x003b1;/IFN&#x003b3; for 48 h. Apoptosis was decreased by zVAD, DEVD and IETD. &#x0002a;p&#x0003c;0.001 vs control and # p&#x0003c;0.0005 vs TNF&#x003b1;/IFN&#x003b3;. Mean&#x000b1;SEM of 6 independent experiments.</p></caption><graphic xlink:href="pone.0006634.g002"/></fig></sec><sec id="s2c"><title>Impaired wound healing in the presence of a proinflammatory milieu is not rescued by caspase inhibition</title><p>Acute demesothelization during peritonitis, unless very severe, is usually a reversible response, and mesothelial cells later repopulate the denuded area. In a wound healing system of HPMC we studied recovery from injury in the absence of exogenous survival factors, aiming to reproduce the adverse microenvironmental conditions of the inflamed peritoneum. Under control conditions, in the absence of proinflammatory cytokines, the mesothelial covering of the wound increased over 48 h (<xref ref-type="fig" rid="pone-0006634-g003"><bold>Fig. 3.A, B</bold></xref>). Caspase inhibition tended to stall the process at late time points. The continuous presence of TNF&#x003b1; and IFN&#x003b3; prevented wound healing. Inhibition of caspases by zVAD did not rescue wound healing among cells treated TNF&#x003b1; and IFN&#x003b3; (<xref ref-type="fig" rid="pone-0006634-g003"><bold>Fig. 3.A, B</bold></xref>). IETD and DEVD caspase inhibitors offered no advantage over zVAD (not shown).</p><fig id="pone-0006634-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0006634.g003</object-id><label>Figure 3</label><caption><title>Inflammatory cytokines retard remesothelization.</title><p>A) Wound healing in HPMC. Contrast phase microscopy. Cells were preincubated with caspase inhibitor or vehicle and cultured in presence of proinflammatory TNF&#x003b1;/IFN&#x003b3; or control media. Original magnification 20&#x000d7;. B) Quantification of wound healing as number of HPMC cells filling the denuded area (cells/mm<sup>2</sup>). In presence of cytokines there is delayed wound healing that is not improved by zVAD.&#x0002a; p&#x0003c;0.03 control vs. TNF&#x003b1;/IFN&#x003b3; and control vs TNF&#x003b1;/IFN&#x003b3;/zVAD. Mean&#x000b1;SEM of 5 different experiments.</p></caption><graphic xlink:href="pone.0006634.g003"/></fig></sec><sec id="s2d"><title>A nanoconjugate Apaf-1 inhibitor prevents cytokine-induced apoptosis and promotes wound healing</title><p>Formation of the apoptosome is a key event in the apoptotic signaling pathway. First-in-class polyglutamic acid (PGA)-based Apaf-1 inhibitor nanoconjugates (PGA-peptoids) are well suited for in vivo applications <xref ref-type="bibr" rid="pone.0006634-Malet1">&#x0005b;30&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0006634-Lee2">&#x0005b;32&#x0005d;</xref>. The PGA-peptoid QM56 prevented, in a dose-dependent manner, mesothelial cell apoptosis induced by a combination of cytokines, as shown for HOMC (<xref ref-type="fig" rid="pone-0006634-g004"><bold>Fig. 4.A</bold></xref>). The QM56 concentration chosen for the rest of the experiments (10 &#x000b5;M) had an antiapoptotic activity similar to 200 &#x000b5;M zVAD (<xref ref-type="fig" rid="pone-0006634-g004"><bold>Fig. 4.A</bold></xref>). In cultured mesothelial cells QM56 prevented caspase-3 processing induced by cytokines, as shown for HOMC (<xref ref-type="fig" rid="pone-0006634-g004"><bold>Fig. 4.B</bold></xref>) and completely prevented the increase in caspase 3 activity induced by TNF&#x003b1;/IFN&#x003b3; in these cells (TNF&#x003b1;/IFN&#x003b3; 1,7&#x000b1;0.4 vs TNF&#x003b1;/IFN&#x003b3;/QM56 0,56&#x000b1;0.18 fold over control, p&#x0003c;0.03, not shown). Similar to observations with caspase inhibitors, QM56 prevented apoptosis induced by TNF&#x003b1; and IFN&#x003b3; in mesothelial cells, as shown for HPMC (<xref ref-type="fig" rid="pone-0006634-g004"><bold>Fig. 4.C,D</bold></xref>). QM56 did not modify the percentage of cells in the S&#x0002b;M phases of the cell cycle (not shown). By contrast to classical caspase inhibitors, QM56 restored the wound healing capacity of mesothelial cells in the presence of cytokines, as shown for HPMC (<xref ref-type="fig" rid="pone-0006634-g005"><bold>Fig. 5.A, B</bold></xref>).</p><fig id="pone-0006634-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0006634.g004</object-id><label>Figure 4</label><caption><title>A nanoconjugate Apaf-1 inhibitor (PGA-peptoid QM56) inhibits caspase activation and apoptosis.</title><p>A) Quantification of apoptosis in HOMC by flow cytometry. HOMC were preincubated with different concentrations of inhibitors or vehicle and cultured with TNF&#x003b1; and IFN&#x003b3; for 48 hours. Mean&#x000b1;SEM of 3 different experiments &#x0002a;p&#x0003c;0.001vs TNF&#x003b1;/IFN&#x003b3;. B) QM56 prevents procaspase-3 processing and the appearance of active p17 and p19 caspase-3 fragments 24 h following exposure to TNF&#x003b1;/IFN&#x003b3; in HOMC. zVAD stalled the process of caspase activation at the level of the p21 precursor as previously described <xref ref-type="bibr" rid="pone.0006634-Slee1">&#x0005b;73&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Polverino1">&#x0005b;74&#x0005d;</xref>. Binding of zVAD.fmk to this p21 intermediate blocks its activity <xref ref-type="bibr" rid="pone.0006634-Polverino1">&#x0005b;74&#x0005d;</xref>. Western blot, representative of 3 independent experiments. C) Representative flow cytometry of DNA content diagrams. Cells were preincubated with QM56 and then cultured with TNF&#x003b1;/IFN&#x003b3; for 48 h. Note the decreased number of hypodiploid apoptotic HPMC in TNF&#x003b1;/IFN&#x003b3;/QM56 treated cells (black arrow). Inset: nuclear apoptotic morphology in cells exposed to TNF&#x003b1;/IFN&#x003b3; and stained with DAPI (white arrows). D) Quantification of apoptosis by flow cytometry of DNA content in HPMC. Mean&#x000b1;SEM of 6 different experiments. &#x0002a;p&#x0003c;0.002 vs cells treated with TNF&#x003b1;/IFN&#x003b3;/QM56.</p></caption><graphic xlink:href="pone.0006634.g004"/></fig><fig id="pone-0006634-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0006634.g005</object-id><label>Figure 5</label><caption><title>QM56 preserves remesothelization.</title><p>A) Wound healing in HPMC. Contrast phase microscopy. Cells were preincubated with Apaf-1 inhibitor and cultured in presence of proinflammatory medium (TNF&#x003b1; and IFN&#x003b3;). Original magnification 20&#x000d7;. B) Quantification of wound healing in HPMC as number of cells filling the denuded area (cells/mm<sup>2</sup>). The delayed wound healing induced by TNF&#x003b1;/IFN&#x003b3; is recovered in presence of QM56. &#x0002a; p&#x0003c;0.03 control vs. TNF&#x003b1;/IFN&#x003b3; &#x0002a;&#x0002a; p&#x0003c;0.003 TNF&#x003b1;/IFN&#x003b3;/QM56 vs. TNF&#x003b1;/IFN&#x003b3;. Mean&#x000b1;SEM of 5 different experiments.</p></caption><graphic xlink:href="pone.0006634.g005"/></fig></sec><sec id="s2e"><title>Apaf-1 inhibition, but not caspase inhibition, improves long-term recovery from inflammatory injury</title><p>We next explored the potential long-term consequences of caspase inhibition in the context of transient, short-term inflammation. Cells were cultured for 24 to 48 h in the presence of TNF&#x003b1; and IFN&#x003b3; with or without inhibitors and then trypsinized, seeded in new plaques and left to recover for 5 days in the presence of survival factors from serum but in the absence of cytokines or inhibitors. This mimics intraperitoneal events during the recovery from human peritonitis with an adequate response to antibiotics. Despite the acute increase in cell death and delayed wound healing observed in the presence of TNF&#x003b1; and IFN&#x003b3;, the removal of these cytokines from the media and the addition of exogenous survival factors was associated with a degree of recovery close to that obtained in control HPMC (<xref ref-type="fig" rid="pone-0006634-g006"><bold>Fig. 6.A</bold></xref>). The initial presence of the cytokine combination and the pan-caspase inhibitor led to a reduced final cell number, suggesting loss of regenerative potential (<xref ref-type="fig" rid="pone-0006634-g006"><bold>Fig. 6.A</bold></xref>). Similar results were observed in HOMC from non-dialysis patients (<xref ref-type="fig" rid="pone-0006634-g006"><bold>Fig. 6.B,C</bold></xref>). Short-term exposure of control cells to zVAD did not impair long-term recovery, indicating that this is not an intrinsic toxic effect of zVAD (<xref ref-type="fig" rid="pone-0006634-g006"><bold>Fig. 6.C</bold></xref>).</p><fig id="pone-0006634-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0006634.g006</object-id><label>Figure 6</label><caption><title>Caspase inhibition compromises long-term recovery from inflammatory injury while Apaf-1 inhibition does not.</title><p>A) HPMC plated on twelve-well plates were preincubated with inhibitors or vehicle and exposed to TNF&#x003b1;/IFN&#x003b3; for 24 h. Cells were then trypsinized, washed, and seeded in Petri dishes in the presence of complete medium with 20&#x00025; FCS for 5 days, but without cytokines or inhibitors, to allow for their recovery. Cells were stained with crystal violet after 5 days. Representative of 3 different experiments. B) Similar results were obtained with HOMC. HOMC were preincubated with inhibitors or vehicle and exposed to TNF&#x003b1;/IFN&#x003b3; for 48 h. Then the cells were trypsinized, washed and seeded without inhibitors and cytokines for 5 days. Representative of 4 different experiments. C) Quantification of crystal violet staining in HOMC. Mean&#x000b1;SEM of 4 different experiments. &#x0002a;p&#x0003c;0.03 vs TNF&#x003b1;/IFN&#x003b3;; #p&#x0003c;0.02 vs TNF&#x003b1;/IFN&#x003b3;.</p></caption><graphic xlink:href="pone.0006634.g006"/></fig><p>By contrast to caspase inhibition, QM56 did not impair the long-term regeneration of HPMC or HOMC subjected to an inflammatory milieu (<xref ref-type="fig" rid="pone-0006634-g006"><bold>Fig. 6A&#x02013;C</bold></xref>). Indeed, QM56 significantly improved recovery (<xref ref-type="fig" rid="pone-0006634-g006"><bold>Fig. 6.C</bold></xref>).</p></sec><sec id="s2f"><title>Apaf-1 inhibitor protects from inflammation-induced apoptosis in vivo</title><p>We next explored the potential of QM56 to modulate cell injury in vivo. Cytokeratin fragmentation, a marker of apoptosis that precedes nuclear changes <xref ref-type="bibr" rid="pone.0006634-Santamaria1">&#x0005b;7&#x0005d;</xref>, was chosen because in vivo early apoptotic cells are rapidly expelled from cell monolayers and engulfed by professional phagocytes <xref ref-type="bibr" rid="pone.0006634-Rosenblatt1">&#x0005b;35&#x0005d;</xref>. In mice the intraperitoneal administration of TNF&#x003b1; and IFN&#x003b3; resulted in an increased rate of mesothelial cell apoptosis at 48 h (<xref ref-type="fig" rid="pone-0006634-g007"><bold>Fig. 7</bold></xref>). <italic>S. aureus</italic> peritonitis also resulted in mesothelial cell apoptosis (<xref ref-type="fig" rid="pone-0006634-g008"><bold>Fig. 8</bold></xref>). The Apaf-1 inhibitor QM56 prevented mesothelial cells apoptosis induced by both inflammatory milieus in vivo (<xref ref-type="fig" rid="pone-0006634-g007"><bold>Fig. 7</bold></xref><bold>,</bold><xref ref-type="fig" rid="pone-0006634-g008"><bold>8</bold></xref>).</p><fig id="pone-0006634-g007" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0006634.g007</object-id><label>Figure 7</label><caption><title>QM56 prevents mesothelial cell apoptosis induced by intraperitoneal cytokine administration in vivo.</title><p>Mice were injected ip with 250 ng/mL TNF&#x003b1; and 300 U/mL IFN&#x003b3; at time 0 and sacrificed at 48 h. QM56 or vehicle was administrated 1 h before the cytokines and 5 h later. A) Representative images of Cytodeath (green)/propidium iodide co-staining. Note an increased number of cells with green cytoplasm indicative of caspase-mediated apoptosis in the sample from the mouse injected with TNF&#x003b1;/IFN&#x003b3;. Magnification &#x000d7;120 B) Quantification of positive cells (green) using Image Pro plus software in 5 fields per mouse (around 600 cells). Mean&#x000b1;SEM of 5 mice per group. &#x0002a; p&#x0003c;0.001 vs. control: # p&#x0003c;0.001vs.TNF&#x003b1; IFN&#x003b3;.</p></caption><graphic xlink:href="pone.0006634.g007"/></fig><fig id="pone-0006634-g008" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0006634.g008</object-id><label>Figure 8</label><caption><title>QM56 prevents mesothelial cell apoptosis during <italic>S. aureus</italic> peritonitis in mice.</title><p>Mice were injected ip. with 5&#x000d7;10<sup>8</sup> c.f.u. <italic>S. aureus</italic> at time 0 and sacrificed at 48 h. QM56 or vehicle was administrated 1 h before the <italic>S. aureus</italic> and 5 h later A) Representative images of Cytodeath (green)/propidium iodide co-staining. Note an increased number of cells with green cytoplasm (arrows) indicative of caspase-mediated apoptosis in the sample from the mouse injected with <italic>S. aureus</italic>. Apoptosis was prevented by QM56 Magnification &#x000d7;120. B) Quantification of cytodeath positive cells (green) using Image Pro plus software in 5 fields per mouse (around 600 cells). Mean&#x000b1;SEM of 5 mice per group. &#x0002a; p&#x0003c;0.05 vs control.</p></caption><graphic xlink:href="pone.0006634.g008"/></fig></sec></sec><sec id="s3"><title>Discussion</title><p>We chose mesothelial cell injury as a model for inflammation-induced tissue injury because mesothelial cell loss is a clinical problem in PD. In addition, the easy access to the peritoneal cavity allows the local delivery of therapeutic agents. We now report that in inflammation-induced mesothelial cell injury cytokines cooperate to induce apoptosis in primary cultures of mesothelial cells obtained from either PD patients or non-uremic individuals. We have further explored possible therapeutic strategies to prevent cell injury and have identified Apaf-1 inhibition as a novel approach that prevents acute inflammation-induced mesothelial cell injury and allows recovery.</p><p>Mesothelial cells are lost by apoptosis in the course of human bacterial PD peritonitis <xref ref-type="bibr" rid="pone.0006634-Chen1">&#x0005b;5&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0006634-Santamaria1">&#x0005b;7&#x0005d;</xref>. We now observed an increased mesothelial apoptosis rate in an experimental model of bacterial peritonitis. In the course of peritonitis multiple inflammatory mediators are released locally, including IFN&#x003b3; and TNF&#x003b1; <xref ref-type="bibr" rid="pone.0006634-Dasgupta1">&#x0005b;33&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Brauner1">&#x0005b;34&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Zemel1">&#x0005b;36&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-McLoughlin1">&#x0005b;37&#x0005d;</xref>. Interestingly, the highest peritoneal IFN&#x003b3; and TNF&#x003b1; levels are found in peritonitis caused by highly virulent microorganisms, such as <italic>S. aureus</italic>, precisely the ones that cause more severe demesothelization and that may lead to irreversible peritoneal injury after a single, severe peritonitis episode <xref ref-type="bibr" rid="pone.0006634-Dasgupta1">&#x0005b;33&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Brauner1">&#x0005b;34&#x0005d;</xref>. Since multiple inputs are perceived by cells in a proinflammatory milieu, it is relevant to study the actions of cytokine combinations <xref ref-type="bibr" rid="pone.0006634-Janes1">&#x0005b;12&#x0005d;</xref>. Our studies show that a TNF&#x003b1;/IFN&#x003b3; combination promoted apoptosis of cultured mesothelial cells, and explore novel therapeutic approaches to prevent inflammation-induced tissue injury that do not target TNF&#x003b1; or IFN&#x003b3;. Both TNF&#x003b1; and IFN&#x003b3; are required for an effective antibacterial defense. TNF&#x003b1; antagonists have been marred by an increased rate of severe infections <xref ref-type="bibr" rid="pone.0006634-Crum1">&#x0005b;38&#x0005d;</xref>. This is more obvious with infliximab, which also inhibits IFN&#x003b3; secretion <xref ref-type="bibr" rid="pone.0006634-Crum1">&#x0005b;38&#x0005d;</xref><xref ref-type="bibr" rid="pone.0006634-Saliu1">&#x0005b;39&#x0005d;</xref>. This suggests that during infection rather than antagonize cytokines, we should strive for the selective therapeutic manipulation of their specific adverse effects that promote tissue injury, such as parenchymal cell apoptosis.</p><p>A single episode of very severe peritonitis may cause irreversible demesothelization and peritoneal fibrosis. However, more often peritonitis is mild to severe, and is followed by partial or total recovery of mesothelial integrity. Both the magnitude of the initial acute loss of mesothelium and the ability of cells to regenerate are important factors in the recovery phase. Our experimental design has addressed how therapeutic agents modulate the initial lethal response to inflammation, the subsequent ability of the mesothelium to repopulate a demesothelized area in the presence of ongoing adverse microenvironmental conditions, and the later recovery phase taking place under a milder microenvironment. The continuous presence of inflammatory cytokines increased the rate of apoptosis and impaired regeneration of the mesothelial layer. However, restoration of the normal cell milieu, with disappearance of inflammatory cytokines and the renewed presence of survival factors, lead to recovery. We now show that cytokine-mediated mesothelial cell apoptosis depends on caspase activation and is prevented by caspase inhibition. However, caspase inhibition did not allow mesothelial layer regeneration in the presence of cytokines to proceed, and, more ominously, severely impaired the long-term regeneration of the mesothelium once cytokines were removed. There are several possible explanations for this phenomenon. First, massive induction of necrosis may occur in cells exposed to members of the TNF superfamily when caspases are inhibited <xref ref-type="bibr" rid="pone.0006634-Janes1">&#x0005b;12&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Justo1">&#x0005b;29&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Vercammen1">&#x0005b;40&#x0005d;</xref>. In this regard, caspase inhibitors did not transform a moderate degree of mesothelial cell apoptosis into a catastrophic rate of necrosis, as zVAD/TNF&#x003b1;/IFN&#x003b3; did not increase the percentage of necrotic cells over TNF&#x003b1;/IFN&#x003b3;. However, caspase inhibition may not prevent eventual non-apoptotic death in cells rescued from apoptosis. Second, caspase inhibitors may inhibit non-apoptotic roles of caspases <xref ref-type="bibr" rid="pone.0006634-Yi1">&#x0005b;41&#x0005d;</xref>. Cell migration and mitosis are required to repair a cell monolayer wound <xref ref-type="bibr" rid="pone.0006634-Haider1">&#x0005b;42&#x0005d;</xref>. Recently a spate of non-apoptotic caspase actions on cell proliferation and migration have been described that favor the recovery process <xref ref-type="bibr" rid="pone.0006634-Ben1">&#x0005b;26&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0006634-Li2">&#x0005b;28&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Kondo1">&#x0005b;43&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Wells1">&#x0005b;44&#x0005d;</xref>. As an example, TNF&#x003b1; is deleterious for the liver in the course of inflammation, through induction of apoptosis <xref ref-type="bibr" rid="pone.0006634-Ding1">&#x0005b;45&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Bradham1">&#x0005b;46&#x0005d;</xref>. However, liver regeneration following partial hepatectomy requires TNF&#x003b1; signaling through the TNFR-1 receptor and caspase-8 activation that primes hepatocytes to respond to mitogens <xref ref-type="bibr" rid="pone.0006634-Ben1">&#x0005b;26&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Yamada1">&#x0005b;47&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Webber1">&#x0005b;48&#x0005d;</xref>. Caspase-3 and caspase- 11 may promote cell migration <xref ref-type="bibr" rid="pone.0006634-Zhao1">&#x0005b;27&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Li2">&#x0005b;28&#x0005d;</xref>.</p><p>Chemical inhibition of Apaf-1 by a nanoconjugate molecule <xref ref-type="bibr" rid="pone.0006634-Malet1">&#x0005b;30&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Vicent1">&#x0005b;31&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Mondragon1">&#x0005b;49&#x0005d;</xref> prevented mesothelial cell apoptosis induced by the combination of cytokines in cell culture and in vivo, suggesting that Apaf-1 is required for mesothelial cell death to occur. This suggests that mitochondria are engaged during TNF-induced mesothelial cell apoptosis and, thus, that mesothelial cells should be considered type II with regard to their response to death receptor activation <xref ref-type="bibr" rid="pone.0006634-Chen2">&#x0005b;50&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0006634-Ashkenazi1">&#x0005b;53&#x0005d;</xref>. Following release of cytochrome c from mitochondria, Apaf-1 is required for caspase-9 activation, setting in motion a rapid amplification of the death signal through activation of caspase-3 and downstream caspases leading to further mitochondrial injury <xref ref-type="bibr" rid="pone.0006634-Bao1">&#x0005b;54&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0006634-Franklin1">&#x0005b;56&#x0005d;</xref>. Contrary to caspase inhibitors, the inhibitor of Apaf-1 also restored the wound healing capacity and promoted long-term recovery of mesothelium. Two, non-mutually exclusive hypothesis, might explain the differences observed between caspase and Apaf-1 inhibitors. In one of them additional functions of caspases, resulting from caspase activation not mediated by proapoptotic stimuli, and, thus, not targeted by inhibition of Apaf-1, may explain the differences. In the previous paragraph we mentioned several non-apoptotic functions of caspases that may not be targeted by the Apaf-1 inhibitor. In addition, as an example, in the absence of cellular stress human glioblastoma cells exhibit a constitutive activation of caspases <italic>in vivo</italic> and <italic>in vitro</italic>. Basal caspase 3 and caspase 8 activity promotes migration and invasiveness in glioblastoma cells and inhibition of caspases decreases the migration and the invasiveness of cells <xref ref-type="bibr" rid="pone.0006634-Gdynia1">&#x0005b;57&#x0005d;</xref>. The administration of low doses of caspase inhibitors may block glioma cell motility without affecting the execution of apoptotic cell death <xref ref-type="bibr" rid="pone.0006634-Gdynia1">&#x0005b;57&#x0005d;</xref>. In the second hypothesis, additional functions of Apaf-1 inhibitors, unrelated to caspases, may underlie this observation. For example, inhibition of the recently described cell cycle arrest induced by Apaf-1 <xref ref-type="bibr" rid="pone.0006634-Zermati1">&#x0005b;58&#x0005d;</xref>. Although the role of Apaf-1 in the DNA damage checkpoint may raise concerns on the carcinogenicity of Apaf-1 targeting, life-long lack of Apaf-1 in Apaf-1-/- mice has not been reported to result in an increased incidence of tumors <xref ref-type="bibr" rid="pone.0006634-Cecconi1">&#x0005b;59&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Yoshida1">&#x0005b;60&#x0005d;</xref>. Additional actions of the Apaf-1 inhibitor cannot be excluded, since a related compound, in addition to inhibiting both functions of Apaf-1, also protects mitochondria <xref ref-type="bibr" rid="pone.0006634-Mondragon1">&#x0005b;49&#x0005d;</xref>. The therapeutic potential of the Apaf-1 inhibitor was confirmed in vivo, where it prevented mesothelial cell loss induced by either TNF&#x003b1;/IFN&#x003b3; or by bacterial peritonitis. Certain stimuli, such as osmotic stress and Staphylococcus aureus promote mesothelial cell death with features of apoptosis that is no prevented by caspase inhibitors <xref ref-type="bibr" rid="pone.0006634-Gastaldello1">&#x0005b;16&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-HaslingerLoffler1">&#x0005b;18&#x0005d;</xref>. It will be interesting to test the efficacy of Apaf-1 inhibitors in preventing cell death in these models.</p><p>In this paper we have focused on the monomicrobial peritonitis characteristic of PD as a proof-of-concept model. In humans these peritonitis are routinely treated by the intraperitoneal administration of therapeutic agents, as used in our models. Polymicrobial peritonitis resulting from visceral perforation, as exemplified by the cecal ligation and puncture model is also a clinically relevant model <xref ref-type="bibr" rid="pone.0006634-Hubbard1">&#x0005b;61&#x0005d;</xref>. However, intravenous therapy is used in humans with perforated bowels, and thus would be the most relevant rout to be studied in animals. This route presents currently unresolved pharmacokinetic issues with the Apaf-1 inhibitor we used. Apaf-1 inhibitors should also be tested in this model in future studies.</p><p>In summary, our data indicate that a chemical compound targeting Apaf-1 prevented inflammation-induced tissue damage, exemplified by the peritoneum, without the adverse consequences of approaches targeting caspases. Our data offer a word of caution when considering the use of caspase inhibitors in the clinical setting: the potential benefits obtained by limiting the initial apoptosis wave may be offset by an impaired recovery from parenchymal cell injury.</p></sec><sec sec-type="materials|methods" id="s4"><title>Materials and Methods</title><sec id="s4a"><title>Mesothelial cell cultures</title><p>The study was approved by the clinical ethics committee of Fundaci&#x000f3;n Jim&#x000e9;nez D&#x000ed;az and written informed consent was obtained. Human peritoneal mesothelial cell (HPMC) were cultured from peritoneal effluents from 6 stable CAPD patients as previously described <xref ref-type="bibr" rid="pone.0006634-Catalan1">&#x0005b;6&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Diaz1">&#x0005b;62&#x0005d;</xref>. Human omental mesothelial cells (HOMC) were obtained from omentum from 6 non-PD patients who underwent unrelated elective abdominal surgery <xref ref-type="bibr" rid="pone.0006634-YanezMo1">&#x0005b;63&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Stylianou1">&#x0005b;64&#x0005d;</xref>.</p></sec><sec id="s4b"><title>Reagents</title><p>Human IFN&#x003b3; and TNF&#x003b1; (Peprotech, London, UK) were used at concentrations based on prior experience with other cell types <xref ref-type="bibr" rid="pone.0006634-Ortiz3">&#x0005b;22&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Lorz1">&#x0005b;65&#x0005d;</xref> and expected to occur in vivo during peritonitis, specially in patients infected with highly virulent bacteria such as <italic>S. aureus</italic>, adjusted for PD fluid dilution <xref ref-type="bibr" rid="pone.0006634-Dasgupta1">&#x0005b;33&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Brauner1">&#x0005b;34&#x0005d;</xref>. Peritoneal effluent concentrations of 4.5 ng/ml TNF&#x003b1; and 45 U/ml IFN&#x003b3; have been reported in the effluents of PD patients <xref ref-type="bibr" rid="pone.0006634-Dasgupta1">&#x0005b;33&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Brauner1">&#x0005b;34&#x0005d;</xref>. Higher cytokine concentrations may be reached locally in mesothelial cells in close contact with paracrine cytokine-secreting leukocytes, as well as in non-PD peritonitis, which lacks the diluting effect of PD solutions. The combination of 100 U/mL (5 ng/mL) TNF&#x003b1; and 20 U/mL IFN&#x003b3; already increased significantly the rate of apoptosis in HOMC by 1.5 fold, but the effect increased with dose up of 250 U/mL TNF&#x003b1; and 300 U/mL IFN&#x003b3;, which were used if not otherwise specified. The antiapoptotic polymeric nanomedicine, PGA-peptoid QM56, is the result of the conjugation of a novel Apaf-1 inhibitor (peptoid 1) to poly-L-glutamic acid (PGA) <xref ref-type="bibr" rid="pone.0006634-Malet1">&#x0005b;30&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Vicent1">&#x0005b;31&#x0005d;</xref>. The initial dose range was chosen based on published dose-response curves and dose-response studies in human mesothelial cells induced to undergo apoptosis by exposure to staurosporin (<xref ref-type="supplementary-material" rid="pone.0006634.s001">Figure S1</xref>) <xref ref-type="bibr" rid="pone.0006634-Malet1">&#x0005b;30&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Vicent1">&#x0005b;31&#x0005d;</xref>. Additional dose-response studies were performed in HOMC exposed to IFN&#x003b3; and TNF&#x003b1; and the concentration chosen for the rest of the studies was 10 &#x000b5;M. The dose of caspase inhibitors was based on previous dose-response studies <xref ref-type="bibr" rid="pone.0006634-Lorz2">&#x0005b;66&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Ortiz4">&#x0005b;67&#x0005d;</xref>. In addition dose-response studies were performed in HOMC exposed to IFN&#x003b3; and TNF&#x003b1; and the concentration chosen for the rest of the studies was 200 &#x000b5;M zVAD.</p></sec><sec id="s4c"><title>Studies of cell death and cleavage by caspases</title><p>Mesothelial cells were cultured to subconfluence in twelve-well plates and rested in serum-free media for 24 h. Then, IFN&#x003b3; and/or TNF&#x003b1; were added. Cells were preincubated with apoptosis inhibitors for 1 h. <xref ref-type="bibr" rid="pone.0006634-Catalan2">&#x0005b;24&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Justo2">&#x0005b;68&#x0005d;</xref>.</p><p>Apoptosis was assessed by functional and morphological studies. Cell DNA content was quantified by flow cytometry in permeabilized, propidium iodide-stained cells <xref ref-type="bibr" rid="pone.0006634-Ortiz3">&#x0005b;22&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Lorz1">&#x0005b;65&#x0005d;</xref>. Permeabilization allows entry of propidium iodide in all cells, dead and alive. Apoptotic cells are characterized by a lower DNA content (hypodiploid cells) because of nuclear fragmentation. Caspases are key effectors of apoptosis. Evidence of caspase activation was assessed studying caspase processing by Western blot. In addition, flow cytometry or microscopy was used to quantify the appearance of a specific epitope generated by caspase cleavage of cytokeratin 18 and identified by the M30 cytodeath antibody (Roche Biochemicals, Mannheim, Germany). This epitope is generated only in epithelial and mesothelial cells, not in leukocytes, and is not present in native cytokeratin 18 <xref ref-type="bibr" rid="pone.0006634-Santamaria1">&#x0005b;7&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0006634-Guillermet1">&#x0005b;69&#x0005d;</xref>.</p><p>For morphologic assessment of apoptosis, cells were cultured in chamber slides (Labtek, Nunc, Naperville, IL), fixed with methanol:acetone (1&#x02236;1), and stained with DAPI <xref ref-type="bibr" rid="pone.0006634-Lorz1">&#x0005b;65&#x0005d;</xref>, or FITC-M30 cytodeath (1&#x02236;250 Roche) and propidium iodide. Thus, the typical condensed, shrunk and fragmented nuclei of apoptotic cells were identified</p><p>Trypan blue staining of freshly collected cells was used to assess cell death due to either apoptosis or necrosis <xref ref-type="bibr" rid="pone.0006634-Justo1">&#x0005b;29&#x0005d;</xref>.</p></sec><sec id="s4d"><title>Caspase-3 activity</title><p>HOMC were preincubated with Apaf-1 inhibitor or vehicle and cultured with IFN&#x003b3; and TNF&#x003b1; for 24 hours. Caspase-3 activity (MBL, Japan) was measured following the manufacturer's instructions. In brief, cell extracts (100 &#x000b5;g of protein) were incubated in half-area 96-well plates at 37&#x000b0;C with 200 &#x000b5;M DEVD-pNA peptide in a total volume of 100 &#x000b5;l. The pNA light emission was quantified using a spectrophotometer plate reader at 405 nm. Comparison of the absorbance of pNA from an apoptotic sample with an uninduced control allows determination of the fold increase in caspase activity <xref ref-type="bibr" rid="pone.0006634-Catalan4">&#x0005b;70&#x0005d;</xref>.</p></sec><sec id="s4e"><title>Wound healing</title><p>The wound-healing model was modified from Yung et al. <xref ref-type="bibr" rid="pone.0006634-Yung1">&#x0005b;71&#x0005d;</xref>. Mesothelial cells were cultured to confluence in twelve-well plates and rested in serum-free media for 24 h. The monolayer was injured with a sterile pipette tip and IFN&#x003b3;, TNF&#x003b1; and apoptosis inhibitors were added to serum-free media. Remesothelization was followed for up to 48 h by marking the injured area and counting cells inside it at different time points.</p></sec><sec id="s4f"><title>Long-term recovery</title><p>Long-term recovery was assessed by a modification of the colony-forming assay. Cells in twelve-well plates were exposed to cytokines and apoptosis inhibitor or vehicle for 24-48 h in serum-free media and then trypsinized, washed, and seeded in Petri dishes in the presence of complete medium with 20&#x00025; FCS and without cytokines or inhibitors of apoptosis. Cell number was estimated at 5 days by crystal violet staining, absorbance was measured at 550 nm <xref ref-type="bibr" rid="pone.0006634-Justo3">&#x0005b;72&#x0005d;</xref>.</p></sec><sec id="s4g"><title>Animal model</title><p>C57BL/6 mice, 3 month-old, were injected ip with a single dose of 300 U/mL IFN&#x003b3; and 250 ng/mL TNF&#x003b1;, or 0.5 ml PBS. QM56 (10 &#x000b5;M drug-equiv.) or vehicle (0.5 ml PBS) were administered 1 h before and 5 h later (total 4 groups, 5 mice per group). Mice were sacrificed at 48 h. The dose and timing were based on cell culture results.</p><p><italic>Staphylococcus aureus</italic> ATCC 25923 (American Type Culture Collection, Manassas, VA, USA) was used to induce peritonitis. The experimental protocol was described previously <xref ref-type="bibr" rid="pone.0006634-Catalan3">&#x0005b;25&#x0005d;</xref> C57BL/6 mice, 3 month-old were injected i.p. with 5&#x000d7;10<sup>8</sup> colony forming units (c.f.u.) <italic>S. aureus</italic> in 1 mL PBS or with PBS. At 48 hours mice were sacrificed. Peritonitis was mild and animals had spontaneously cleared <italic>S. aureus</italic> by 48 h.</p><p>In both models mesenteric windows were placed on glass slides and stained with Cytodeath and propidium iodide. Studies were conducted in accord with the NIH Guide for the Care and Use of Laboratory Animals.</p></sec><sec id="s4h"><title>Statistics</title><p>Statistical analysis was performed using SPSS 11.0 statistical software. Results are expressed as mean&#x000b1;SEM. Significance at the p&#x0003c;0.05 level was assessed by Student's t test and one- way ANOVA with Bonferron&#x000ed;'s correction or Mann-Whitney and Kruskal-Wallis tests.</p></sec></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0006634.s001"><label>Figure S1</label><caption><p>Quantification of apoptosis in HPMC by flow cytometryof DNA content. HPMC were preincubated with QM56 for 1 hour and cultured with 100 nM staurosporin(STS) for 24 hours. &#x0002a; p&#x0003c;0.001 vscontrol (co) or different concentrations of inhibitor. Mean&#x000b1;semof 4 different experiments.</p><p>(0.33 MB TIF)</p></caption><media xlink:href="pone.0006634.s001.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We thank Mar&#x000ed;a M. Gonz&#x000e1;lez Garcia-Parre&#x000f1;o for assistance with confocal microscopy, Prof Angel Messeguer for the synthesis of the peptoid inhibitors of Apaf-1 and Susana Carrasco for technical assistance.</p></ack><ref-list><title>References</title><ref id="pone.0006634-Heimburger1"><label>1</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Heimburger</surname><given-names>O</given-names></name><name><surname>Blake</surname><given-names>PG</given-names></name></person-group><year>2007</year><article-title>Apparatus for peritoneal dialysis.</article-title><person-group person-group-type="editor"><name><surname>Daugirdas</surname><given-names>JT</given-names></name><name><surname>Blake</surname><given-names>PG</given-names></name><name><surname>Ing</surname><given-names>TS</given-names></name></person-group><source>Handbook of dialysis, 4<sup>a</sup>ed</source><publisher-loc>Philadelphia</publisher-loc><publisher-name>Lippincot Williams Wilkins</publisher-name><fpage>339</fpage><lpage>355</lpage></mixed-citation></ref><ref id="pone.0006634-Piraino1"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piraino</surname><given-names>B</given-names></name><name><surname>Bailie</surname><given-names>GR</given-names></name><name><surname>Bernardini</surname><given-names>J</given-names></name><name><surname>Boeschoten</surname><given-names>E</given-names></name><name><surname>Gupta</surname><given-names>A</given-names></name><etal/></person-group><year>2005</year><article-title>Peritoneal dialysis-related infections recommendations: 2005 update.</article-title><source>Perit Dial Int</source><volume>25</volume><fpage>107</fpage><lpage>131</lpage><pub-id pub-id-type="pmid">15796137</pub-id></mixed-citation></ref><ref id="pone.0006634-Di1"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di</surname><given-names>PN</given-names></name><name><surname>Sacchi</surname><given-names>G</given-names></name></person-group><year>2000</year><article-title>Atlas of peritoneal histology.</article-title><source>Perit Dial Int</source><volume>20</volume><issue>Suppl 3</issue><fpage>S5</fpage><lpage>96</lpage></mixed-citation></ref><ref id="pone.0006634-Verger1"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verger</surname><given-names>C</given-names></name><name><surname>Luger</surname><given-names>A</given-names></name><name><surname>Moore</surname><given-names>HL</given-names></name><name><surname>Nolph</surname><given-names>KD</given-names></name></person-group><year>1983</year><article-title>Acute changes in peritoneal morphology and transport properties with infectious peritonitis and mechanical injury.</article-title><source>Kidney Int</source><volume>23</volume><fpage>823</fpage><lpage>831</lpage><pub-id pub-id-type="pmid">6887693</pub-id></mixed-citation></ref><ref id="pone.0006634-Chen1"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>JY</given-names></name><name><surname>Chi</surname><given-names>CW</given-names></name><name><surname>Chen</surname><given-names>HL</given-names></name><name><surname>Wan</surname><given-names>CP</given-names></name><name><surname>Yang</surname><given-names>WC</given-names></name><etal/></person-group><year>2003</year><article-title>TNF-alpha renders human peritoneal mesothelial cells sensitive to anti-Fas antibody-induced apoptosis.</article-title><source>Nephrol Dial Transplant</source><volume>18</volume><fpage>1741</fpage><lpage>1747</lpage><pub-id pub-id-type="pmid">12937219</pub-id></mixed-citation></ref><ref id="pone.0006634-Catalan1"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catalan</surname><given-names>MP</given-names></name><name><surname>Subira</surname><given-names>D</given-names></name><name><surname>Reyero</surname><given-names>A</given-names></name><name><surname>Selgas</surname><given-names>R</given-names></name><name><surname>Ortiz-Gonzalez</surname><given-names>A</given-names></name><etal/></person-group><year>2003</year><article-title>Regulation of apoptosis by lethal cytokines in human mesothelial cells.</article-title><source>Kidney Int</source><volume>64</volume><fpage>321</fpage><lpage>330</lpage><pub-id pub-id-type="pmid">12787425</pub-id></mixed-citation></ref><ref id="pone.0006634-Santamaria1"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santamaria</surname><given-names>B</given-names></name><name><surname>Ucero</surname><given-names>AC</given-names></name><name><surname>Reyero</surname><given-names>A</given-names></name><name><surname>Selgas</surname><given-names>R</given-names></name><name><surname>Ruiz-Ortega</surname><given-names>M</given-names></name><etal/></person-group><year>2008</year><article-title>3,4-Dideoxyglucosone-3-ene as a mediator of peritoneal demesothelization.</article-title><source>Nephrol Dial Transplant</source><volume>23</volume><fpage>3307</fpage><lpage>3315</lpage><pub-id pub-id-type="pmid">18524790</pub-id></mixed-citation></ref><ref id="pone.0006634-Baker1"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>AJ</given-names></name><name><surname>Mooney</surname><given-names>A</given-names></name><name><surname>Hughes</surname><given-names>J</given-names></name><name><surname>Lombardi</surname><given-names>D</given-names></name><name><surname>Johnson</surname><given-names>RJ</given-names></name><etal/></person-group><year>1994</year><article-title>Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis.</article-title><source>J Clin Invest</source><volume>94</volume><fpage>2105</fpage><lpage>2116</lpage><pub-id pub-id-type="pmid">7962557</pub-id></mixed-citation></ref><ref id="pone.0006634-Ortiz1"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortiz</surname><given-names>A</given-names></name><name><surname>Catalan</surname><given-names>MP</given-names></name></person-group><year>2004</year><article-title>Will modulation of cell death increase PD technique survival?</article-title><source>Perit Dial Int</source><volume>24</volume><fpage>105</fpage><lpage>114</lpage><pub-id pub-id-type="pmid">15119631</pub-id></mixed-citation></ref><ref id="pone.0006634-Marchi1"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchi</surname><given-names>E</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Broaddus</surname><given-names>VC</given-names></name></person-group><year>2000</year><article-title>Mesothelial cell apoptosis is confirmed in vivo by morphological change in cytokeratin distribution.</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><volume>278</volume><fpage>L528</fpage><lpage>L535</lpage><pub-id pub-id-type="pmid">10710525</pub-id></mixed-citation></ref><ref id="pone.0006634-Heath1"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heath</surname><given-names>RM</given-names></name><name><surname>Jayne</surname><given-names>DG</given-names></name><name><surname>O'Leary</surname><given-names>R</given-names></name><name><surname>Morrison</surname><given-names>EE</given-names></name><name><surname>Guillou</surname><given-names>PJ</given-names></name></person-group><year>2004</year><article-title>Tumour-induced apoptosis in human mesothelial cells: a mechanism of peritoneal invasion by Fas Ligand/Fas interaction.</article-title><source>Br J Cancer</source><volume>90</volume><fpage>1437</fpage><lpage>1442</lpage><pub-id pub-id-type="pmid">15054468</pub-id></mixed-citation></ref><ref id="pone.0006634-Janes1"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janes</surname><given-names>KA</given-names></name><name><surname>Albeck</surname><given-names>JG</given-names></name><name><surname>Gaudet</surname><given-names>S</given-names></name><name><surname>Sorger</surname><given-names>PK</given-names></name><name><surname>Lauffenburger</surname><given-names>DA</given-names></name><etal/></person-group><year>2005</year><article-title>A systems model of signaling identifies a molecular basis set for cytokine-induced apoptosis.</article-title><source>Science</source><volume>310</volume><fpage>1646</fpage><lpage>1653</lpage><pub-id pub-id-type="pmid">16339439</pub-id></mixed-citation></ref><ref id="pone.0006634-Broaddus1"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broaddus</surname><given-names>VC</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Scavo</surname><given-names>LM</given-names></name><name><surname>Ernst</surname><given-names>JD</given-names></name><name><surname>Boylan</surname><given-names>AM</given-names></name></person-group><year>1996</year><article-title>Asbestos induces apoptosis of human and rabbit pleural mesothelial cells via reactive oxygen species.</article-title><source>J Clin Invest</source><volume>98</volume><fpage>2050</fpage><lpage>2059</lpage><pub-id pub-id-type="pmid">8903324</pub-id></mixed-citation></ref><ref id="pone.0006634-Jimenez1"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jimenez</surname><given-names>LA</given-names></name><name><surname>Zanella</surname><given-names>C</given-names></name><name><surname>Fung</surname><given-names>H</given-names></name><name><surname>Janssen</surname><given-names>YM</given-names></name><name><surname>Vacek</surname><given-names>P</given-names></name><etal/></person-group><year>1997</year><article-title>Role of extracellular signal-regulated protein kinases in apoptosis by asbestos and H2O2.</article-title><source>Am J Physiol</source><volume>273</volume><fpage>L1029</fpage><lpage>L1035</lpage><pub-id pub-id-type="pmid">9374731</pub-id></mixed-citation></ref><ref id="pone.0006634-Szeto1"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szeto</surname><given-names>CC</given-names></name><name><surname>Chow</surname><given-names>KM</given-names></name><name><surname>Lai</surname><given-names>KB</given-names></name><name><surname>Szeto</surname><given-names>CY</given-names></name><name><surname>Kwan</surname><given-names>BC</given-names></name><etal/></person-group><year>2006</year><article-title>Connective tissue growth factor is responsible for transforming growth factor-beta-induced peritoneal mesothelial cell apoptosis.</article-title><source>Nephron Exp Nephrol</source><volume>103</volume><fpage>e166</fpage><lpage>e174</lpage><pub-id pub-id-type="pmid">16636587</pub-id></mixed-citation></ref><ref id="pone.0006634-Gastaldello1"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gastaldello</surname><given-names>K</given-names></name><name><surname>Husson</surname><given-names>C</given-names></name><name><surname>Dondeyne</surname><given-names>JP</given-names></name><name><surname>Vanherweghem</surname><given-names>JL</given-names></name><name><surname>Tielemans</surname><given-names>C</given-names></name></person-group><year>2008</year><article-title>Cytotoxicity of mononuclear cells as induced by peritoneal dialysis fluids: insight into mechanisms that regulate osmotic stress-related apoptosis.</article-title><source>Perit Dial Int</source><volume>28</volume><fpage>655</fpage><lpage>666</lpage><pub-id pub-id-type="pmid">18981398</pub-id></mixed-citation></ref><ref id="pone.0006634-Lee1"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>DH</given-names></name><name><surname>Choi</surname><given-names>SY</given-names></name><name><surname>Ryu</surname><given-names>HM</given-names></name><name><surname>Kim</surname><given-names>CD</given-names></name><name><surname>Park</surname><given-names>SH</given-names></name><etal/></person-group><year>2009</year><article-title>3,4-dideoxyglucosone-3-ene induces apoptosis in human peritoneal mesothelial cells.</article-title><source>Perit Dial Int</source><volume>29</volume><fpage>44</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">19164252</pub-id></mixed-citation></ref><ref id="pone.0006634-HaslingerLoffler1"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haslinger-Loffler</surname><given-names>B</given-names></name><name><surname>Wagner</surname><given-names>B</given-names></name><name><surname>Bruck</surname><given-names>M</given-names></name><name><surname>Strangfeld</surname><given-names>K</given-names></name><name><surname>Grundmeier</surname><given-names>M</given-names></name><etal/></person-group><year>2006</year><article-title>Staphylococcus aureus induces caspase-independent cell death in human peritoneal mesothelial cells.</article-title><source>Kidney Int</source><volume>70</volume><fpage>1089</fpage><lpage>1098</lpage><pub-id pub-id-type="pmid">16871245</pub-id></mixed-citation></ref><ref id="pone.0006634-Ortiz2"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortiz</surname><given-names>A</given-names></name></person-group><year>2000</year><article-title>Nephrology forum: apoptotic regulatory proteins in renal injury.</article-title><source>Kidney Int</source><volume>58</volume><fpage>467</fpage><lpage>485</lpage><pub-id pub-id-type="pmid">10886604</pub-id></mixed-citation></ref><ref id="pone.0006634-Sanz1"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanz</surname><given-names>AB</given-names></name><name><surname>Santamaria</surname><given-names>B</given-names></name><name><surname>Ruiz-Ortega</surname><given-names>M</given-names></name><name><surname>Egido</surname><given-names>J</given-names></name><name><surname>Ortiz</surname><given-names>A</given-names></name></person-group><year>2008</year><article-title>Mechanisms of renal apoptosis in health and disease.</article-title><source>J Am Soc Nephrol</source><volume>19</volume><fpage>1634</fpage><lpage>1642</lpage><pub-id pub-id-type="pmid">18632846</pub-id></mixed-citation></ref><ref id="pone.0006634-Strasser1"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strasser</surname><given-names>A</given-names></name><name><surname>O'Connor</surname><given-names>L</given-names></name><name><surname>Dixit</surname><given-names>VM</given-names></name></person-group><year>2000</year><article-title>Apoptosis signaling.</article-title><source>Annu Rev Biochem</source><volume>69</volume><fpage>217</fpage><lpage>245</lpage><pub-id pub-id-type="pmid">10966458</pub-id></mixed-citation></ref><ref id="pone.0006634-Ortiz3"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortiz</surname><given-names>A</given-names></name><name><surname>Lorz</surname><given-names>C</given-names></name><name><surname>Catalan</surname><given-names>MP</given-names></name><name><surname>Danoff</surname><given-names>TM</given-names></name><name><surname>Yamasaki</surname><given-names>Y</given-names></name><etal/></person-group><year>2000</year><article-title>Expression of apoptosis regulatory proteins in tubular epithelium stressed in culture or following acute renal failure.</article-title><source>Kidney Int</source><volume>57</volume><fpage>969</fpage><lpage>981</lpage><pub-id pub-id-type="pmid">10720950</pub-id></mixed-citation></ref><ref id="pone.0006634-Li1"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Nijhawan</surname><given-names>D</given-names></name><name><surname>Budihardjo</surname><given-names>I</given-names></name><name><surname>Srinivasula</surname><given-names>SM</given-names></name><name><surname>Ahmad</surname><given-names>M</given-names></name><etal/></person-group><year>1997</year><article-title>Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade.</article-title><source>Cell</source><volume>91</volume><fpage>479</fpage><lpage>489</lpage><pub-id pub-id-type="pmid">9390557</pub-id></mixed-citation></ref><ref id="pone.0006634-Catalan2"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catalan</surname><given-names>MP</given-names></name><name><surname>Reyero</surname><given-names>A</given-names></name><name><surname>Egido</surname><given-names>J</given-names></name><name><surname>Ortiz</surname><given-names>A</given-names></name></person-group><year>2001</year><article-title>Acceleration of neutrophil apoptosis by glucose-containing peritoneal dialysis solutions: role of caspases.</article-title><source>J Am Soc Nephrol</source><volume>12</volume><fpage>2442</fpage><lpage>2449</lpage><pub-id pub-id-type="pmid">11675421</pub-id></mixed-citation></ref><ref id="pone.0006634-Catalan3"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catalan</surname><given-names>MP</given-names></name><name><surname>Esteban</surname><given-names>J</given-names></name><name><surname>Subira</surname><given-names>D</given-names></name><name><surname>Egido</surname><given-names>J</given-names></name><name><surname>Ortiz</surname><given-names>A</given-names></name></person-group><year>2003</year><article-title>Inhibition of caspases improves bacterial clearance in experimental peritonitis.</article-title><source>Perit Dial Int</source><volume>23</volume><fpage>123</fpage><lpage>126</lpage><pub-id pub-id-type="pmid">12713077</pub-id></mixed-citation></ref><ref id="pone.0006634-Ben1"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben</surname><given-names>MT</given-names></name><name><surname>Barash</surname><given-names>H</given-names></name><name><surname>Kang</surname><given-names>TB</given-names></name><name><surname>Kim</surname><given-names>JC</given-names></name><name><surname>Kovalenko</surname><given-names>A</given-names></name><etal/></person-group><year>2007</year><article-title>Role of caspase-8 in hepatocyte response to infection and injury in mice.</article-title><source>Hepatology</source><volume>45</volume><fpage>1014</fpage><lpage>1024</lpage><pub-id pub-id-type="pmid">17385212</pub-id></mixed-citation></ref><ref id="pone.0006634-Zhao1"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Xiao</surname><given-names>Y</given-names></name><name><surname>Sengupta</surname><given-names>S</given-names></name><etal/></person-group><year>2006</year><article-title>Caspase-3-dependent activation of calcium-independent phospholipase A2 enhances cell migration in non-apoptotic ovarian cancer cells.</article-title><source>J Biol Chem</source><volume>281</volume><fpage>29357</fpage><lpage>29368</lpage><pub-id pub-id-type="pmid">16882668</pub-id></mixed-citation></ref><ref id="pone.0006634-Li2"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Brieher</surname><given-names>WM</given-names></name><name><surname>Scimone</surname><given-names>ML</given-names></name><name><surname>Kang</surname><given-names>SJ</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><etal/></person-group><year>2007</year><article-title>Caspase-11 regulates cell migration by promoting Aip1-Cofilin-mediated actin depolymerization.</article-title><source>Nat Cell Biol</source><volume>9</volume><fpage>276</fpage><lpage>286</lpage><pub-id pub-id-type="pmid">17293856</pub-id></mixed-citation></ref><ref id="pone.0006634-Justo1"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Justo</surname><given-names>P</given-names></name><name><surname>Sanz</surname><given-names>AB</given-names></name><name><surname>Sanchez-Nino</surname><given-names>MD</given-names></name><name><surname>Winkles</surname><given-names>JA</given-names></name><name><surname>Lorz</surname><given-names>C</given-names></name><etal/></person-group><year>2006</year><article-title>Cytokine cooperation in renal tubular cell injury: the role of TWEAK.</article-title><source>Kidney Int</source><volume>70</volume><fpage>1750</fpage><lpage>1758</lpage><pub-id pub-id-type="pmid">17003819</pub-id></mixed-citation></ref><ref id="pone.0006634-Malet1"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malet</surname><given-names>G</given-names></name><name><surname>Martin</surname><given-names>AG</given-names></name><name><surname>Orzaez</surname><given-names>M</given-names></name><name><surname>Vicent</surname><given-names>MJ</given-names></name><name><surname>Masip</surname><given-names>I</given-names></name><etal/></person-group><year>2006</year><article-title>Small molecule inhibitors of Apaf-1-related caspase- 3/-9 activation that control mitochondrial-dependent apoptosis.</article-title><source>Cell Death Differ</source><volume>13</volume><fpage>1523</fpage><lpage>1532</lpage><pub-id pub-id-type="pmid">16341125</pub-id></mixed-citation></ref><ref id="pone.0006634-Vicent1"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vicent</surname><given-names>MJ</given-names></name><name><surname>Perez-Paya</surname><given-names>E</given-names></name></person-group><year>2006</year><article-title>Poly-L-glutamic acid (PGA) aided inhibitors of apoptotic protease activating factor 1 (Apaf-1): an antiapoptotic polymeric nanomedicine.</article-title><source>J Med Chem</source><volume>49</volume><fpage>3763</fpage><lpage>3765</lpage><pub-id pub-id-type="pmid">16789732</pub-id></mixed-citation></ref><ref id="pone.0006634-Lee2"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JC</given-names></name><name><surname>Schickling</surname><given-names>O</given-names></name><name><surname>Stegh</surname><given-names>AH</given-names></name><name><surname>Oshima</surname><given-names>RG</given-names></name><name><surname>Dinsdale</surname><given-names>D</given-names></name><etal/></person-group><year>2002</year><article-title>DEDD regulates degradation of intermediate filaments during apoptosis.</article-title><source>J Cell Biol</source><volume>158</volume><fpage>1051</fpage><lpage>1066</lpage><pub-id pub-id-type="pmid">12235123</pub-id></mixed-citation></ref><ref id="pone.0006634-Dasgupta1"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dasgupta</surname><given-names>MK</given-names></name><name><surname>Larabie</surname><given-names>M</given-names></name><name><surname>Halloran</surname><given-names>PF</given-names></name></person-group><year>1994</year><article-title>Interferon-gamma levels in peritoneal dialysis effluents: relation to peritonitis.</article-title><source>Kidney Int</source><volume>46</volume><fpage>475</fpage><lpage>481</lpage><pub-id pub-id-type="pmid">7967361</pub-id></mixed-citation></ref><ref id="pone.0006634-Brauner1"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brauner</surname><given-names>A</given-names></name><name><surname>Hylander</surname><given-names>B</given-names></name><name><surname>Wretlind</surname><given-names>B</given-names></name></person-group><year>1996</year><article-title>Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-1 receptor antagonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis.</article-title><source>Am J Kidney Dis</source><volume>27</volume><fpage>402</fpage><lpage>408</lpage><pub-id pub-id-type="pmid">8604710</pub-id></mixed-citation></ref><ref id="pone.0006634-Rosenblatt1"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenblatt</surname><given-names>J</given-names></name><name><surname>Raff</surname><given-names>MC</given-names></name><name><surname>Cramer</surname><given-names>LP</given-names></name></person-group><year>2001</year><article-title>An epithelial cell destined for apoptosis signals its neighbors to extrude it by an actin- and myosin-dependent mechanism.</article-title><source>Curr Biol</source><volume>11</volume><fpage>1847</fpage><lpage>1857</lpage><pub-id pub-id-type="pmid">11728307</pub-id></mixed-citation></ref><ref id="pone.0006634-Zemel1"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zemel</surname><given-names>D</given-names></name><name><surname>Imholz</surname><given-names>AL</given-names></name><name><surname>de Waart</surname><given-names>DR</given-names></name><name><surname>Dinkla</surname><given-names>C</given-names></name><name><surname>Struijk</surname><given-names>DG</given-names></name><etal/></person-group><year>1994</year><article-title>Appearance of tumor necrosis factor-alpha and soluble TNF-receptors I and II in peritoneal effluent of CAPD.</article-title><source>Kidney Int</source><volume>46</volume><fpage>1422</fpage><lpage>1430</lpage><pub-id pub-id-type="pmid">7853803</pub-id></mixed-citation></ref><ref id="pone.0006634-McLoughlin1"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLoughlin</surname><given-names>RM</given-names></name><name><surname>Witowski</surname><given-names>J</given-names></name><name><surname>Robson</surname><given-names>RL</given-names></name><name><surname>Wilkinson</surname><given-names>TS</given-names></name><name><surname>Hurst</surname><given-names>SM</given-names></name><etal/></person-group><year>2003</year><article-title>Interplay between IFN-gamma and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation.</article-title><source>J Clin Invest</source><volume>112</volume><fpage>598</fpage><lpage>607</lpage><pub-id pub-id-type="pmid">12925700</pub-id></mixed-citation></ref><ref id="pone.0006634-Crum1"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crum</surname><given-names>NF</given-names></name><name><surname>Lederman</surname><given-names>ER</given-names></name><name><surname>Wallace</surname><given-names>MR</given-names></name></person-group><year>2005</year><article-title>Infections associated with tumor necrosis factor-alpha antagonists.</article-title><source>Medicine (Baltimore)</source><volume>84</volume><fpage>291</fpage><lpage>302</lpage><pub-id pub-id-type="pmid">16148729</pub-id></mixed-citation></ref><ref id="pone.0006634-Saliu1"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saliu</surname><given-names>OY</given-names></name><name><surname>Sofer</surname><given-names>C</given-names></name><name><surname>Stein</surname><given-names>DS</given-names></name><name><surname>Schwander</surname><given-names>SK</given-names></name><name><surname>Wallis</surname><given-names>RS</given-names></name></person-group><year>2006</year><article-title>Tumor-necrosis-factor blockers: differential effects on mycobacterial immunity.</article-title><source>J Infect Dis</source><volume>194</volume><fpage>486</fpage><lpage>492</lpage><pub-id pub-id-type="pmid">16845632</pub-id></mixed-citation></ref><ref id="pone.0006634-Vercammen1"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vercammen</surname><given-names>D</given-names></name><name><surname>Brouckaert</surname><given-names>G</given-names></name><name><surname>Denecker</surname><given-names>G</given-names></name><name><surname>Van de</surname><given-names>CM</given-names></name><name><surname>Declercq</surname><given-names>W</given-names></name><etal/></person-group><year>1998</year><article-title>Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways.</article-title><source>J Exp Med</source><volume>188</volume><fpage>919</fpage><lpage>930</lpage><pub-id pub-id-type="pmid">9730893</pub-id></mixed-citation></ref><ref id="pone.0006634-Yi1"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>CH</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name></person-group><year>2009</year><article-title>The Jekyll and Hyde functions of caspases.</article-title><source>Dev Cell</source><volume>16</volume><fpage>21</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">19154716</pub-id></mixed-citation></ref><ref id="pone.0006634-Haider1"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haider</surname><given-names>AS</given-names></name><name><surname>Grabarek</surname><given-names>J</given-names></name><name><surname>Eng</surname><given-names>B</given-names></name><name><surname>Pedraza</surname><given-names>P</given-names></name><name><surname>Ferreri</surname><given-names>NR</given-names></name><etal/></person-group><year>2003</year><article-title>In vitro model of &#x0201c;wound healing&#x0201d; analyzed by laser scanning cytometry: accelerated healing of epithelial cell monolayers in the presence of hyaluronate.</article-title><source>Cytometry A</source><volume>53</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">12701127</pub-id></mixed-citation></ref><ref id="pone.0006634-Kondo1"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kondo</surname><given-names>S</given-names></name><name><surname>Senoo-Matsuda</surname><given-names>N</given-names></name><name><surname>Hiromi</surname><given-names>Y</given-names></name><name><surname>Miura</surname><given-names>M</given-names></name></person-group><year>2006</year><article-title>DRONC coordinates cell death and compensatory proliferation.</article-title><source>Mol Cell Biol</source><volume>26</volume><fpage>7258</fpage><lpage>7268</lpage><pub-id pub-id-type="pmid">16980627</pub-id></mixed-citation></ref><ref id="pone.0006634-Wells1"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wells</surname><given-names>BS</given-names></name><name><surname>Yoshida</surname><given-names>E</given-names></name><name><surname>Johnston</surname><given-names>LA</given-names></name></person-group><year>2006</year><article-title>Compensatory proliferation in Drosophila imaginal discs requires Dronc-dependent p53 activity.</article-title><source>Curr Biol</source><volume>16</volume><fpage>1606</fpage><lpage>1615</lpage><pub-id pub-id-type="pmid">16920621</pub-id></mixed-citation></ref><ref id="pone.0006634-Ding1"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>WX</given-names></name><name><surname>Yin</surname><given-names>XM</given-names></name></person-group><year>2004</year><article-title>Dissection of the multiple mechanisms of TNF-alpha-induced apoptosis in liver injury.</article-title><source>J Cell Mol Med</source><volume>8</volume><fpage>445</fpage><lpage>454</lpage><pub-id pub-id-type="pmid">15601573</pub-id></mixed-citation></ref><ref id="pone.0006634-Bradham1"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bradham</surname><given-names>CA</given-names></name><name><surname>Plumpe</surname><given-names>J</given-names></name><name><surname>Manns</surname><given-names>MP</given-names></name><name><surname>Brenner</surname><given-names>DA</given-names></name><name><surname>Trautwein</surname><given-names>C</given-names></name></person-group><year>1998</year><article-title>Mechanisms of hepatic toxicity. I. TNF-induced liver injury.</article-title><source>Am J Physiol</source><volume>275</volume><fpage>G387</fpage><lpage>G392</lpage><pub-id pub-id-type="pmid">9724248</pub-id></mixed-citation></ref><ref id="pone.0006634-Yamada1"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>Y</given-names></name><name><surname>Webber</surname><given-names>EM</given-names></name><name><surname>Kirillova</surname><given-names>I</given-names></name><name><surname>Peschon</surname><given-names>JJ</given-names></name><name><surname>Fausto</surname><given-names>N</given-names></name></person-group><year>1998</year><article-title>Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor.</article-title><source>Hepatology</source><volume>28</volume><fpage>959</fpage><lpage>970</lpage><pub-id pub-id-type="pmid">9755232</pub-id></mixed-citation></ref><ref id="pone.0006634-Webber1"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Webber</surname><given-names>EM</given-names></name><name><surname>Bruix</surname><given-names>J</given-names></name><name><surname>Pierce</surname><given-names>RH</given-names></name><name><surname>Fausto</surname><given-names>N</given-names></name></person-group><year>1998</year><article-title>Tumor necrosis factor primes hepatocytes for DNA replication in the rat.</article-title><source>Hepatology</source><volume>28</volume><fpage>1226</fpage><lpage>1234</lpage><pub-id pub-id-type="pmid">9794905</pub-id></mixed-citation></ref><ref id="pone.0006634-Mondragon1"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mondragon</surname><given-names>L</given-names></name><name><surname>Galluzzi</surname><given-names>L</given-names></name><name><surname>Mouhamad</surname><given-names>S</given-names></name><name><surname>Orzaez</surname><given-names>M</given-names></name><name><surname>Vicencio</surname><given-names>JM</given-names></name><etal/></person-group><year>2009</year><article-title>A chemical inhibitor of Apaf-1 exerts mitochondrioprotective functions and interferes with the intra-S-phase DNA damage checkpoint.</article-title><source>Apoptosis</source><volume>14</volume><fpage>182</fpage><lpage>190</lpage><pub-id pub-id-type="pmid">19152031</pub-id></mixed-citation></ref><ref id="pone.0006634-Chen2"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Ding</surname><given-names>WX</given-names></name><name><surname>Ni</surname><given-names>HM</given-names></name><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>Shi</surname><given-names>YH</given-names></name><etal/></person-group><year>2007</year><article-title>Bid-independent mitochondrial activation in tumor necrosis factor alpha-induced apoptosis and liver injury.</article-title><source>Mol Cell Biol</source><volume>27</volume><fpage>541</fpage><lpage>553</lpage><pub-id pub-id-type="pmid">17101783</pub-id></mixed-citation></ref><ref id="pone.0006634-Pei1"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pei</surname><given-names>Y</given-names></name><name><surname>Xing</surname><given-names>D</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>T</given-names></name></person-group><year>2007</year><article-title>Real-time monitoring full length bid interacting with Bax during TNF-alpha-induced apoptosis.</article-title><source>Apoptosis</source><volume>12</volume><fpage>1681</fpage><lpage>1690</lpage><pub-id pub-id-type="pmid">17520191</pub-id></mixed-citation></ref><ref id="pone.0006634-Wang1"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Singh</surname><given-names>R</given-names></name><name><surname>Lefkowitch</surname><given-names>JH</given-names></name><name><surname>Rigoli</surname><given-names>RM</given-names></name><name><surname>Czaja</surname><given-names>MJ</given-names></name></person-group><year>2006</year><article-title>Tumor necrosis factor-induced toxic liver injury results from JNK2-dependent activation of caspase-8 and the mitochondrial death pathway.</article-title><source>J Biol Chem</source><volume>281</volume><fpage>15258</fpage><lpage>15267</lpage><pub-id pub-id-type="pmid">16571730</pub-id></mixed-citation></ref><ref id="pone.0006634-Ashkenazi1"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashkenazi</surname><given-names>A</given-names></name><name><surname>Dixit</surname><given-names>VM</given-names></name></person-group><year>1998</year><article-title>Death receptors: signaling and modulation.</article-title><source>Science</source><volume>281</volume><fpage>1305</fpage><lpage>1308</lpage><pub-id pub-id-type="pmid">9721089</pub-id></mixed-citation></ref><ref id="pone.0006634-Bao1"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bao</surname><given-names>Q</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name></person-group><year>2007</year><article-title>Apoptosome: a platform for the activation of initiator caspases.</article-title><source>Cell Death Differ</source><volume>14</volume><fpage>56</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">16977332</pub-id></mixed-citation></ref><ref id="pone.0006634-Hill1"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>MM</given-names></name><name><surname>Adrain</surname><given-names>C</given-names></name><name><surname>Martin</surname><given-names>SJ</given-names></name></person-group><year>2003</year><article-title>Portrait of a killer: the mitochondrial apoptosome emerges from the shadows.</article-title><source>Mol Interv</source><volume>3</volume><fpage>19</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">14993435</pub-id></mixed-citation></ref><ref id="pone.0006634-Franklin1"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franklin</surname><given-names>EE</given-names></name><name><surname>Robertson</surname><given-names>JD</given-names></name></person-group><year>2007</year><article-title>Requirement of Apaf-1 for mitochondrial events and the cleavage or activation of all procaspases during genotoxic stress-induced apoptosis.</article-title><source>Biochem J</source><volume>405</volume><fpage>115</fpage><lpage>122</lpage><pub-id pub-id-type="pmid">17348858</pub-id></mixed-citation></ref><ref id="pone.0006634-Gdynia1"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gdynia</surname><given-names>G</given-names></name><name><surname>Grund</surname><given-names>K</given-names></name><name><surname>Eckert</surname><given-names>A</given-names></name><name><surname>Bock</surname><given-names>BC</given-names></name><name><surname>Funke</surname><given-names>B</given-names></name><etal/></person-group><year>2007</year><article-title>Basal caspase activity promotes migration and invasiveness in glioblastoma cells.</article-title><source>Mol Cancer Res</source><volume>5</volume><fpage>1232</fpage><lpage>1240</lpage><pub-id pub-id-type="pmid">18171980</pub-id></mixed-citation></ref><ref id="pone.0006634-Zermati1"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zermati</surname><given-names>Y</given-names></name><name><surname>Mouhamad</surname><given-names>S</given-names></name><name><surname>Stergiou</surname><given-names>L</given-names></name><name><surname>Besse</surname><given-names>B</given-names></name><name><surname>Galluzzi</surname><given-names>L</given-names></name><etal/></person-group><year>2007</year><article-title>Nonapoptotic role for Apaf-1 in the DNA damage checkpoint.</article-title><source>Mol Cell</source><volume>28</volume><fpage>624</fpage><lpage>637</lpage><pub-id pub-id-type="pmid">18042457</pub-id></mixed-citation></ref><ref id="pone.0006634-Cecconi1"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cecconi</surname><given-names>F</given-names></name><name><surname>varez-Bolado</surname><given-names>G</given-names></name><name><surname>Meyer</surname><given-names>BI</given-names></name><name><surname>Roth</surname><given-names>KA</given-names></name><name><surname>Gruss</surname><given-names>P</given-names></name></person-group><year>1998</year><article-title>Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development.</article-title><source>Cell</source><volume>94</volume><fpage>727</fpage><lpage>737</lpage><pub-id pub-id-type="pmid">9753320</pub-id></mixed-citation></ref><ref id="pone.0006634-Yoshida1"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>H</given-names></name><name><surname>Kong</surname><given-names>YY</given-names></name><name><surname>Yoshida</surname><given-names>R</given-names></name><name><surname>Elia</surname><given-names>AJ</given-names></name><name><surname>Hakem</surname><given-names>A</given-names></name><etal/></person-group><year>1998</year><article-title>Apaf1 is required for mitochondrial pathways of apoptosis and brain development.</article-title><source>Cell</source><volume>94</volume><fpage>739</fpage><lpage>750</lpage><pub-id pub-id-type="pmid">9753321</pub-id></mixed-citation></ref><ref id="pone.0006634-Hubbard1"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hubbard</surname><given-names>WJ</given-names></name><name><surname>Choudhry</surname><given-names>M</given-names></name><name><surname>Schwacha</surname><given-names>MG</given-names></name><name><surname>Kerby</surname><given-names>JD</given-names></name><name><surname>Rue</surname><given-names>LW</given-names><suffix>III</suffix></name><etal/></person-group><year>2005</year><article-title>Cecal ligation and puncture.</article-title><source>Shock</source><volume>24</volume><issue>Suppl 1</issue><fpage>52</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">16374373</pub-id></mixed-citation></ref><ref id="pone.0006634-Diaz1"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diaz</surname><given-names>C</given-names></name><name><surname>Selgas</surname><given-names>R</given-names></name><name><surname>Castro</surname><given-names>MA</given-names></name><name><surname>Bajo</surname><given-names>MA</given-names></name><name><surname>Fernandez de</surname><given-names>CM</given-names></name><etal/></person-group><year>1998</year><article-title>Ex vivo proliferation of mesothelial cells directly obtained from peritoneal effluent: its relationship with peritoneal antecedents and functional parameters.</article-title><source>Adv Perit Dial</source><volume>14</volume><fpage>19</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">10649684</pub-id></mixed-citation></ref><ref id="pone.0006634-YanezMo1"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yanez-Mo</surname><given-names>M</given-names></name><name><surname>Lara-Pezzi</surname><given-names>E</given-names></name><name><surname>Selgas</surname><given-names>R</given-names></name><name><surname>Ramirez-Huesca</surname><given-names>M</given-names></name><name><surname>Dominguez-Jimenez</surname><given-names>C</given-names></name><etal/></person-group><year>2003</year><article-title>Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells.</article-title><source>N Engl J Med</source><volume>348</volume><fpage>403</fpage><lpage>413</lpage><pub-id pub-id-type="pmid">12556543</pub-id></mixed-citation></ref><ref id="pone.0006634-Stylianou1"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stylianou</surname><given-names>E</given-names></name><name><surname>Jenner</surname><given-names>LA</given-names></name><name><surname>Davies</surname><given-names>M</given-names></name><name><surname>Coles</surname><given-names>GA</given-names></name><name><surname>Williams</surname><given-names>JD</given-names></name></person-group><year>1990</year><article-title>Isolation, culture and characterization of human peritoneal mesothelial cells.</article-title><source>Kidney Int</source><volume>37</volume><fpage>1563</fpage><lpage>1570</lpage><pub-id pub-id-type="pmid">2362409</pub-id></mixed-citation></ref><ref id="pone.0006634-Lorz1"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorz</surname><given-names>C</given-names></name><name><surname>Ortiz</surname><given-names>A</given-names></name><name><surname>Justo</surname><given-names>P</given-names></name><name><surname>Gonzalez-Cuadrado</surname><given-names>S</given-names></name><name><surname>Duque</surname><given-names>N</given-names></name><etal/></person-group><year>2000</year><article-title>Proapoptotic Fas ligand is expressed by normal kidney tubular epithelium and injured glomeruli.</article-title><source>J Am Soc Nephrol</source><volume>11</volume><fpage>1266</fpage><lpage>1277</lpage><pub-id pub-id-type="pmid">10864583</pub-id></mixed-citation></ref><ref id="pone.0006634-Lorz2"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorz</surname><given-names>C</given-names></name><name><surname>Justo</surname><given-names>P</given-names></name><name><surname>Sanz</surname><given-names>A</given-names></name><name><surname>Subira</surname><given-names>D</given-names></name><name><surname>Egido</surname><given-names>J</given-names></name><etal/></person-group><year>2004</year><article-title>Paracetamol-induced renal tubular injury: a role for ER stress.</article-title><source>J Am Soc Nephrol</source><volume>15</volume><fpage>380</fpage><lpage>389</lpage><pub-id pub-id-type="pmid">14747384</pub-id></mixed-citation></ref><ref id="pone.0006634-Ortiz4"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortiz</surname><given-names>A</given-names></name><name><surname>Lorz</surname><given-names>C</given-names></name><name><surname>Catalan</surname><given-names>M</given-names></name><name><surname>Ortiz</surname><given-names>A</given-names></name><name><surname>Coca</surname><given-names>S</given-names></name><etal/></person-group><year>1998</year><article-title>Cyclosporine A induces apoptosis in murine tubular epithelial cells: role of caspases.</article-title><source>Kidney Int Suppl</source><volume>68</volume><fpage>S25</fpage><lpage>S29</lpage><pub-id pub-id-type="pmid">9839279</pub-id></mixed-citation></ref><ref id="pone.0006634-Justo2"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Justo</surname><given-names>P</given-names></name><name><surname>Sanz</surname><given-names>AB</given-names></name><name><surname>Lorz</surname><given-names>C</given-names></name><name><surname>Egido</surname><given-names>J</given-names></name><name><surname>Ortiz</surname><given-names>A</given-names></name></person-group><year>2006</year><article-title>Lethal activity of FADD death domain in renal tubular epithelial cells.</article-title><source>Kidney Int</source><volume>69</volume><fpage>2205</fpage><lpage>2211</lpage><pub-id pub-id-type="pmid">16688118</pub-id></mixed-citation></ref><ref id="pone.0006634-Guillermet1"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guillermet</surname><given-names>J</given-names></name><name><surname>Saint-Laurent</surname><given-names>N</given-names></name><name><surname>Rochaix</surname><given-names>P</given-names></name><name><surname>Cuvillier</surname><given-names>O</given-names></name><name><surname>Levade</surname><given-names>T</given-names></name><etal/></person-group><year>2003</year><article-title>Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis.</article-title><source>Proc Natl Acad Sci U S A</source><volume>100</volume><fpage>155</fpage><lpage>160</lpage><pub-id pub-id-type="pmid">12490654</pub-id></mixed-citation></ref><ref id="pone.0006634-Catalan4"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catalan</surname><given-names>MP</given-names></name><name><surname>Santamaria</surname><given-names>B</given-names></name><name><surname>Reyero</surname><given-names>A</given-names></name><name><surname>Ortiz</surname><given-names>A</given-names></name><name><surname>Egido</surname><given-names>J</given-names></name><etal/></person-group><year>2005</year><article-title>3,4-di-deoxyglucosone-3-ene promotes leukocyte apoptosis.</article-title><source>Kidney Int</source><volume>68</volume><fpage>1303</fpage><lpage>1311</lpage><pub-id pub-id-type="pmid">16105065</pub-id></mixed-citation></ref><ref id="pone.0006634-Yung1"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yung</surname><given-names>S</given-names></name><name><surname>Davies</surname><given-names>M</given-names></name></person-group><year>1998</year><article-title>Response of the human peritoneal mesothelial cell to injury: an in vitro model of peritoneal wound healing.</article-title><source>Kidney Int</source><volume>54</volume><fpage>2160</fpage><lpage>2169</lpage><pub-id pub-id-type="pmid">9853283</pub-id></mixed-citation></ref><ref id="pone.0006634-Justo3"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Justo</surname><given-names>P</given-names></name><name><surname>Lorz</surname><given-names>C</given-names></name><name><surname>Sanz</surname><given-names>A</given-names></name><name><surname>Egido</surname><given-names>J</given-names></name><name><surname>Ortiz</surname><given-names>A</given-names></name></person-group><year>2003</year><article-title>Intracellular mechanisms of cyclosporin A-induced tubular cell apoptosis.</article-title><source>J Am Soc Nephrol</source><volume>14</volume><fpage>3072</fpage><lpage>3080</lpage><pub-id pub-id-type="pmid">14638906</pub-id></mixed-citation></ref><ref id="pone.0006634-Slee1"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slee</surname><given-names>EA</given-names></name><name><surname>Harte</surname><given-names>MT</given-names></name><name><surname>Kluck</surname><given-names>RM</given-names></name><name><surname>Wolf</surname><given-names>BB</given-names></name><name><surname>Casiano</surname><given-names>CA</given-names></name><etal/></person-group><year>1999</year><article-title>Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner.</article-title><source>J Cell Biol</source><volume>144</volume><fpage>281</fpage><lpage>292</lpage><pub-id pub-id-type="pmid">9922454</pub-id></mixed-citation></ref><ref id="pone.0006634-Polverino1"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polverino</surname><given-names>AJ</given-names></name><name><surname>Patterson</surname><given-names>SD</given-names></name></person-group><year>1997</year><article-title>Selective activation of caspases during apoptotic induction in HL-60 cells. Effects Of a tetrapeptide inhibitor.</article-title><source>J Biol Chem</source><volume>272</volume><fpage>7013</fpage><lpage>7021</lpage><pub-id pub-id-type="pmid">9054391</pub-id></mixed-citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>Research grants from Fresenius Medical care and Baxter Healthcare have gone to Alberto Ortiz and Rafael Selgas. Research grants from Gambro have gone to Rafael Selgas.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>Grant support: ISCIII (01/0199, 06/0046, ISCIII-RETIC REDinREN/RD06/0016, Comunidad de Madrid/FRACM/S-BIO0283/2006, Sociedad Espanola de Nefrologi&#x000ad;a, and Fresenius Medical Care, Programa Intensificacion Actividad Investigadora Sistema Nacional de Salud ISCIII/CM to AO, MEC (BIO2004-998 and BIO2007-60066) to EPP, MEC (CTQ2007-60601) and GVA (GV07/070) to MJV. BS and ACU were supported by Fundacion Conchita Rabago and AB by Fondo de Investigaciones Sanitarias (FIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group></back></article>